Vital Stats From Our Heart Failure and Electrophysiology Programs

Below we share recent volumes and clinical outcomes from two programs in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute: heart failure and recovery, and electrophysiology and cardiac pacing.

HEART FAILURE AND RECOVERY

2022 VOLUMES

66 Number of heart transplants, including 5 in pediatric patients and 1 heart/lung transplant

72 Number of left ventricular assist device (LVAD) implantations

312 Number of patient referrals for advanced heart failure

HEART TRANSPLANT

40% lower Best estimate of Cleveland Clinic’s risk of 1-year graft failure vs. the national average

49% lower Best estimate of Cleveland Clinic’s risk of 3-year graft failure vs. the national average

(Source: Scientific Registry of Transplant Recipients program report of 1/5/23)

LVAD IMPLANTATION

246 Number of LVAD implants over the past 3 years (97 in 2020, 77 in 2021, 72 in 2022), among the highest volumes in the United States

87.5% 1-year post-implant survival, primary LVADs (vs. 86.3% STS Intermacs survival)*

87.6% 1-year post-implant survival, continuous-flow LVADs for destination therapy (vs. 83.2% STS Intermacs survival)*

*For the period 7/1/21-12/31/22.

(Source: Society of Thoracic Surgeons [STS] Intermacs Quarterly Quality Assurance Report, 2022 Q4)

ELECTROPHYSIOLOGY (EP)

OVERALL VOLUME

30,926 EP lab procedure volume, 2018-2022

6,434 EP lab procedure volume, 2022

LEAD EXTRACTION

861 Lead extraction procedures, 2018-2022

95.9% Clinical success rate for lead extractions

0.12% In-hospital mortality, vs. benchmark of 1.2% (Kusumoto et al., Heart Rhythm. 2017)

ATRIAL FIBRILLATION ABLATION

6,125 Atrial fibrillation ablations, 2018-2022

1.78% Major complication rate, vs. benchmark of 2.5% (Hsu et al., J Am Coll Cardiol. 2023)

VENTRICULAR ARRHYTHMIA ABLATION

1,318 Ventricular arrhythmia ablations, 2018-2022

3.9% Major complication rate, vs. benchmark of 10% (Cronin et al., Heart Rhythm. 2020)

LEFT ATRIAL APPENDAGE OCCLUSION (LAAO)

904 Watchman™ and Amplatzer Amulet™ devices placed for LAAO procedures (inclusive of EP and interventional cases), 2018-2022

2.2% Major complication rate within 7 days of LAAO device implant, vs. benchmark of 2.7-8.7% in published trials (Boersma et al., Eur Heart J. 2016)

For more data like this, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.